DNA RNA and Cells

03 Jun 2008 Oncogenex reports that low serum clusterin levels were predictive of survival in preliminary analyses of phase 2 study of lead drug candidate OGX-011
03 Jun 2008 Calando Pharmaceuticals Doses First Patient in siRNA Phase I Clinical Trial
02 Jun 2008 Biovex reports positive phase II clinical trial results of Oncovexgm-CSF in metastatic melanoma at the 2008 American Society of Clinical Oncology Meeting
30 May 2008 BioAlliance Pharma Presents New Results on its AMEP(TM) anti-invasive biotherapy
30 May 2008 VIRxSYS Presents New VRX496 Phase II HIV Gene Therapy Trial Data
30 May 2008 AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011
30 May 2008 Genasense(R) Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma
30 May 2008 Targeted Genetics Reports Additional Data From Inflammatory Arthritis Clinical Trial
29 May 2008 Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
28 May 2008 Santaris Pharma begins human clinical testing of the world’s first medicine targeted at a human microRNA
28 May 2008 ADVEXIN(R) Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients
27 May 2008 Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi TherapeuticsAlnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
21 May 2008 Cell Genesys Reports Encouraging Interim Data From Phase 1 Clinical Trial of CG0070 in Recurrent Bladder Cancer
19 May 2008 Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder with Tengion Neo-Bladder Replacement(TM)
16 May 2008 OncoGenex reports updated survival data on OGX-011 in a second-line chemotherapy trial for patients with prostate cancer
15 May 2008 FDA Places Geron’s GRNOPC1 IND on Clinical Hold
13 May 2008 AVI BioPharma Announces Significant Advance in the Potential Treatment of Ebola and Marburg Virus Infections
12 May 2008 Argos Therapeutics Initiates Phase 2 Proof-of-Concept Trial for its Arcelis(TM) Personalized Immunotherapy Platform in HIV
09 May 2008 Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
09 May 2008 Osiris and NuVasive Enter into Definitive Agreement for Osteocel(R)
08 May 2008 Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
07 May 2008 FDA and the Paul Ehrlich Institute (Germany) Approve Pluristem’s Regulatory Submissions in Support of a Phase I/II Clinical Trial Utilizing PLX-PAD for Peripheral Artery Disease
05 May 2008 MOLOGEN AG receives approval for clinical study with cancer drug MGN1703
02 May 2008 Celgene Cellular Therapeutics Announces Clinical Transplant of Human Placenta-Derived Stem Cells
30 Apr 2008 Topigen reports progess toward clinical trials for TPI 1100 at Rnai World CongressTopigen reports progess toward clinical trials for TPI 1100 at Rnai World Congress

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top